Replies to post #3123 on ANI Pharmaceuticals (ANIP)

[toomanyjobs]

I dislike Motley Fool most of the time. They find a stock which is gaining attention that day and write an article. The article tells you really nothing but at the end they hype what they want and that is to subscribe to their rant! Example...I know XYZ is up 40% today but if you really want a good stock click on this opportunity.
Anip looks great today...patience rewarded maybe

[Just the facts maam]

Jeff, I see a couple of possibilities but the most likely is tied to Libigel.

So far Biosante shareholders have benefited from the merger to a greater extent then ANI shareholders have. The Biosante pipeline has yet to get original ANI shareholders anything but being listed and $18 million. ANI has now established themselves as a company with good future revenue potential from the ANI side of business Possibly worth in excess of %3 billion in 3 to 4 years. This makes the terms of the Merger easier to swallow for former Biosante shareholders. Now it is time to show the original ANI shareholders why they gave up 43 % of their company (there were cheaper ways to get listed)

July 2014 is the estimated primary completion of The Testosterone trial for Older Men. I suspect the results will be favorable and justify a similar trial for post-menopausal women. ANI already has the safety data, the Phase II efficacy data on Cognitive Function trial plus what ever efficacy they referred to in the safety trial.

The trial for women would most likely involve the following organizations:

National Institute on Aging (NIA)
National Institute of Neurological Disorders and Stroke (NINDS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Heart, Lung, and Blood Institute (NHLBI)
In addition to:
Abbvie(Possibly Teva)
Abbott (for diagnostic testing)
ANI (supply of Libigel)

If efficacy is buried in the safety trial, then the FDA will be looking for post marketing studies. If as Pryzbyl stated to me last August, ANI still intends to seek a partner to co-promote Libigel then the shelf registration may very well be tied to it.

I believe until this deal with ABBVIE is consummated we will see Majority ownership stay tied to insiders and passive institutions.


JMHO

[Dr PeteRose MLB]

from my seat here on my dozer building the first cut into OAKWOOD ESTATES a restricted building community the brainchild of my older brother John financed mostly by his younger( and better looking I must say) Pete
You don't go bear hunting with a daisy BB gun you want to be loaded up. whether its Libigel or another suite of drugs or if they want to enter the 20 billion dollar pain mgmt sector Elite Pharmacuticals is looking for a partner and I honestly believe it would be an excellent fit with the first Abuse Resistance Opoiod being filed in dec'14 with a projected approval August 2015 for abuse resistant OxyContin a 3 billion dollar drug but who knows I've made lots of cash with both I'd love to see them
together
anyway I believe Arty has a plan and it will make most here happy, a few wouldn't be happy if the crapped gold
Good luck Jeff JTFM Homey Al Rusty Mace n Kingsransome and toomanyjobs
and if yawll Want a deal on a 1.5-2 acre building lot you get the nice price
Pete